Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs.

Oliveri V, Giuffrida ML, Vecchio G, Aiello C, Viale M.

Dalton Trans. 2012 Apr 21;41(15):4530-5. doi: 10.1039/c2dt12371a.

PMID:
22354329
2.

Glycosylated copper(II) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy.

Oliveri V, Viale M, Caron G, Aiello C, Gangemi R, Vecchio G.

Dalton Trans. 2013 Feb 14;42(6):2023-34. doi: 10.1039/c2dt32429f.

PMID:
23174818
3.

Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.

Arafa HM.

Invest New Drugs. 2010 Jun;28(3):306-17. doi: 10.1007/s10637-009-9248-2.

PMID:
19415182
4.

Chemo-enzymatic synthesis of ester-linked docetaxel-monosaccharide conjugates as water-soluble prodrugs.

Shimoda K, Kubota N.

Molecules. 2011 Aug 9;16(8):6769-77. doi: 10.3390/molecules16086769.

5.

Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety.

Freitas LB, Borgati TF, de Freitas RP, Ruiz AL, Marchetti GM, de Carvalho JE, da Cunha EF, Ramalho TC, Alves RB.

Eur J Med Chem. 2014 Sep 12;84:595-604. doi: 10.1016/j.ejmech.2014.07.061.

PMID:
25062010
6.
7.

New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.

Alaoui AE, Saha N, Schmidt F, Monneret C, Florent JC.

Bioorg Med Chem. 2006 Jul 15;14(14):5012-9.

PMID:
16554162
8.
9.

Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines.

Reis DC, Pinto MC, Souza-Fagundes EM, Rocha LF, Pereira VR, Melo CM, Beraldo H.

Biometals. 2011 Aug;24(4):595-601. doi: 10.1007/s10534-011-9407-8.

PMID:
21221718
11.

In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.

Radi M, Adema AD, Daft JR, Cho JH, Hoebe EK, Alexander LE, Peters GJ, Chu CK.

J Med Chem. 2007 May 3;50(9):2249-53.

PMID:
17419604
12.

New cyclodextrin-bearing 8-hydroxyquinoline ligands as multifunctional molecules.

Oliveri V, Puglisi A, Viale M, Aiello C, Sgarlata C, Vecchio G, Clarke J, Milton J, Spencer J.

Chemistry. 2013 Oct 4;19(41):13946-55. doi: 10.1002/chem.201300237.

PMID:
24038335
13.

The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity.

Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, Lee CC.

Methods. 2007 Aug;42(4):377-87.

PMID:
17560325
14.

A new cyclopamine glucuronide prodrug with improved kinetics of drug release.

Renoux B, Legigan T, Bensalma S, Chadéneau C, Muller JM, Papot S.

Org Biomol Chem. 2011 Dec 21;9(24):8459-64. doi: 10.1039/c1ob06081c.

PMID:
22042246
15.
16.

Synthesis and cytotoxicity evaluation of some 8-hydroxyquinoline derivatives.

Shen AY, Wu SN, Chiu CT.

J Pharm Pharmacol. 1999 May;51(5):543-8.

PMID:
10411213
17.

Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.

Wang Y, Xin D, Liu K, Zhu M, Xiang J.

Bioconjug Chem. 2009 Dec;20(12):2214-21. doi: 10.1021/bc8003809.

PMID:
19950889
18.

Design, synthesis, and antitumor activity of bile acid-polyamine-nucleoside conjugates.

Wu D, Ji S, Wu Y, Ju Y, Zhao Y.

Bioorg Med Chem Lett. 2007 Jun 1;17(11):2983-6.

PMID:
17416522
19.

Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.

Tietze LF, Krewer B.

Anticancer Agents Med Chem. 2009 Mar;9(3):304-25. Review.

PMID:
19275523
20.

Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.

Kamal A, Gayatri NL, Reddy DR, Mohan Reddy PS, Arifuddin M, Dastidar SG, Kondapi AK, Rajkumar M.

Bioorg Med Chem. 2005 Nov 15;13(22):6218-25.

PMID:
16061385
Items per page

Supplemental Content

Support Center